- Home
- A-Z Publications
- Current Pharmaceutical Design
- Previous Issues
- Volume 11, Issue 1, 2005
Current Pharmaceutical Design - Volume 11, Issue 1, 2005
Volume 11, Issue 1, 2005
-
-
Editorial [Hot Topic: Prebiotics and Probiotics: Delivering Therapeutics as Dietary Components (Executive Editor: Colum Dunne)]
By Colum DunneThe functionality of dietary components, beyond provision of inherent nutritional benefits, has in relatively recent times become the focus of both lay and scientific interest. The imagination of the public has been captured by the concept that diet has a significant impact on health. The belief that one's quality of life can be enhanced through manipulation of patterns of food intake has resulted in “prebiotic” and, most especiall Read More
-
-
-
Probiotics: An Emerging Therapy
Authors: G. C. O'Sullivan, P. Kelly, S. O'Halloran, C. Collins, J. K. Collins, C. Dunne and F. ShanahanThere is considerable clinical interest in the utility of probiotic therapy - the feeding of (live) non-pathogenic bacteria, originally derived from the alimentary tract, for disease treatment or health promotion. The microflora of the gastrointestinal tract is essential for mucosal protection, for immune education and for metabolism of fecal residue. Physiological disturbances of these processes, when they occur, result from: i) a Read More
-
-
-
The Importance of Guidelines in the Development and Application of Probiotics
By Gregor ReidProbiotics, defined as ''Live microorganisms which when administered in adequate amounts confer a health benefit on the host'' have many attributes including the lack of adverse side effects associated with their use. While probiotics have proven benefits, the optimism associated with their use is counterbalanced by the fact that many so-called 'probiotic' products are unreliable in content and unproven clinically. Theref Read More
-
-
-
Regulating the Safety of Probiotics - The European Approach
More LessThis article reviews pertinent legislation regulating the safety of probiotics within the European Union (EU). Currently available probiotic organisms and known issues regarding their safety are briefly summarised. While most of the species and genera, particularly lactobacilli and bifidobacteria are apparently safe, certain micro-organisms may be problematic; particularly the enterococci, which are associated with nosocomial in Read More
-
-
-
Mining the Probiotic Genome: Advanced Strategies, Enhanced Benefits, Perceived Obstacles
More LessRecent advances in DNA sequencing has made it possible to accurately decipher the entire genetic complement of a probiotic bacterium. Increases in sequencing capabilities have been enhanced through improved computer software that can annotate, or identify, the majority of genes encoded by the sequence. The availability of annotated genome sequence will be important in defining the capabilities of the individual strains of Read More
-
-
-
Probiotic Research in Australia, New Zealand and the Asia-Pacific Region
Authors: R. Crittenden, A. R. Bird, P. Gopal, A. Henriksson, Y. K. Lee and M. J. PlayneAlthough the epicentres of probiotic research in the past decade have been Japan and Europe, researchers in the Asia-Pacific region have actively contributed to the growing understanding of the intestinal microbial ecosystem, and interactions between gut bacteria, diet and health of the human host. A number of new probiotic strains have been developed in the region that have been demonstrated to have beneficial imp Read More
-
-
-
The Delivery of Probiotics and Prebiotics to Infants
Authors: M. J. Kullen and J. BettlerA number of studies involving the feeding of probiotics and prebiotics to infants have been published over the last decade. These studies have examined a wide range of health outcomes, including growth and safety, prophylaxis and alleviation of diarrheal disease, reduction in atopic disease, reduction in necrotizing enterocolitis, and reduction in infection of the preterm infant. In addition, these studies have described Read More
-
-
-
Modulation of the Human Gut Microflora Towards Improved Health Using Prebiotics - Assessment of Efficacy
Authors: K. M. Tuohy, G. C.M. Rouzaud, W. M. Bruck and G. R. GibsonThere is increasing awareness that the human gut microflora plays a critical role in maintaining host health, both within the gastrointestinal tract and, through the absorption of metabolites, systemically. An 'optimal' gut microflora establishes an efficient barrier to the invasion and colonisation of the gut by pathogenic bacteria, produces a range of metabolic substrates which in turn are utilized by the host (e.g. vitamins and sho Read More
-
Volumes & issues
-
Volume 31 (2025)
-
Volume 30 (2024)
-
Volume 29 (2023)
-
Volume 28 (2022)
-
Volume 27 (2021)
-
Volume 26 (2020)
-
Volume 25 (2019)
-
Volume 24 (2018)
-
Volume 23 (2017)
-
Volume 22 (2016)
-
Volume 21 (2015)
-
Volume 20 (2014)
-
Volume 19 (2013)
-
Volume 18 (2012)
-
Volume 17 (2011)
-
Volume 16 (2010)
-
Volume 15 (2009)
-
Volume 14 (2008)
-
Volume 13 (2007)
-
Volume 12 (2006)
-
Volume 11 (2005)
-
Volume 10 (2004)
-
Volume 9 (2003)
-
Volume 8 (2002)
-
Volume 7 (2001)
-
Volume 6 (2000)
Most Read This Month
Article
content/journals/cpd
Journal
10
5
false
en
